Advisory Services Network’s Cytokinetics CYTK Stock Holding History

Advisory Services Network’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-557	Closed	-$36.7K	–	2731
2026 Q1	$36.7K	Buy	+557	New	+$35.4K	﹤0.01%	2804
2025 Q4	–	Sell	-574	Closed	-$31.5K	–	2371
2025 Q3	$31.5K	Buy	+574	New	+$23.6K	﹤0.01%	2727
2025 Q1	–	Sell	-5,739	Closed	-$270K	–	1644
2024 Q4	$270K	Buy	+5,739	New	+$298K	0.01%	1349
2024 Q1	–	Sell	-950	Closed	-$79.3K	–	1944
2023 Q4	$79.3K	Buy	+950	New	+$34.4K	﹤0.01%	1764
2023 Q2	–	Sell	-1,350	Closed	-$47.5K	–	1945
2023 Q1	$47.5K	Hold	1,350	–	–	﹤0.01%	2046
2022 Q4	$61.9K	Buy	+1,350	New	+$58.1K	﹤0.01%	1870
2021 Q3	–	Sell	-150	Closed	-$3K	–	1817
2021 Q2	$3K	Buy	+150	New	+$3.52K	﹤0.01%	3202
2021 Q1	–	Sell	-150	Closed	-$3K	–	1658
2020 Q4	$3K	Hold	150	–	–	﹤0.01%	2865
2020 Q3	$3K	Buy	+150	New	+$3.51K	﹤0.01%	2931

Other funds holding CYTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's CYTK Position: Q2 2026 in Review

Advisory Services Network sold out of Cytokinetics (CYTK) in Q2 2026, closing a stake of 557 shares — an estimated $36.7K sold.

Advisory Services Network first reported a position in CYTK in Q3 2020 and held it in 9 quarters. The position peaked at $270K in Q4 2024. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

Advisory Services Network reported no remaining Cytokinetics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 557 Cytokinetics shares in Q2 2026, an estimated $36.7K.
Advisory Services Network first reported a position in Cytokinetics in Q3 2020 and held it in 9 quarters.
Advisory Services Network's Cytokinetics position peaked at $270K in Q4 2024.
482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.